Repair of Traumatic Brain Injury | SCCAA – Dove Medical Press

Introduction Traumatic brain injury is one of the main causes of deaths, disabilities, and hospitalization in the world. In the USA, around 30% of all injury-related deaths are due to traumatic brain injury.1 Globally, traumatic brain injury affects the lives of about 10 million people each year.2 It happened as the brain tissue is damaged by an external force, the result of direct impact, rapid acceleration or deceleration, a piercing object, and blast waves from an explosion.3 Visual impairment, cognitive dysfunction, hearing loss, and mental health disorders are among the most common complications affecting traumatic brain injury patients and their families. The pathophysiology of traumatic brain injury is not clear since the structure of the brain is complex with many cell types such as neurons, astrocytes, oligodendrocytes, microglia, and multiple subtypes of these cells

Read more
Live Cell Metabolic Analysis — Paving the Way for Metabolic Research and Cell & Gene Therapy, Upcoming Webinar Hosted by Xtalks – Benzinga

In this free webinar, learn how live cell metabolic analysis paves the way not only for metabolic research, but also the manufacturing of significant cell and gene therapy (CGT) products. Attendees will learn how glycolysis metabolic process can be measured directly through the continuous measuring of glucose and lactate amounts in the culture media using electrochemical sensors which provides new scientific insights.

Read more
Creative Biolabs Introduces List of Immune Cell Products to Expedite CAR-T Therapy Research – Pro News Report

(ProNewsReport Editorial):- New York City, New York Jul 12, 2022 (Issuewire.com)Over the past decade, CAR-T cell therapy, which enlists and strengthens the power of the human immune system to attack tumors, has rapidly become one of the key pillars of cancer treatment. With several drugs approved, CAR-T therapy has covered a wide range of cancer types, including acute lymphoblastic leukemia, B-cell lymphoma, follicular lymphoma, etc., and still shows potential in more diseases

Read more
Global Cell Culture Market Size projected to reach USD 27978.89 Million by 2025 , Share, Outlook, Opportunities, By Type, Application, End Users,…

Cell Culture Market is valued around USD 14870.31Million in 2017 and expected to reach USD 27978.89 Million by 2025 with the CAGR of 9.45 % over the forecast period. Cell culture is a technique in which living cells are isolated from plant or animal body and grown in artificially controlled environment conditions. Cell produced by cell culture can be used for various purposes such as drug discovery, study and others.

Read more
St. Jude Sickle Cell Research Team Warns Geneticists to Choose ‘the Right Mouse for the Job’ – Bio-IT World

July 12, 2022 | In the 1970s, sickle cell disease (SCD)characterized by prolonged bouts of extreme pain, edema, immunodeficiency, and the presence of the eponymous sickle-shaped red blood cellsbecame the first disease identified as a genetic disorder. Once considered on the cutting edge of biomedical research, it inspired many therapeutic interventions

Read more
T-cell Lymphoma Market worth $2.89 billion by 2030 – Exclusive Report by InsightAce Analytic – PR Newswire

JERSEY CITY, N.J., July 12, 2022 /PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global T-cell Lymphoma MarketBy Lymphoma Type (Peripheral T-Cell Lymphoma (Cutaneous T-Cell Lymphoma, Anaplastic Large Cell Lymphoma, Angio-Immuno-Blastic T-Cell Lymphoma, And Others (Intestinal T-Cell Lymphoma, Follicular T-Cell Lymphoma)) And T-Cell Lymphoblastic Lymphoma), Therapy (Radiotherapy, Chemotherapy, Immunotherapy, Stem Cell Transplantation, And Others (Antiviral Treatment, Etc.)- Trends, Industry Competition Analysis, Revenue and Forecast To 2030." According to the latest research by InsightAce Analytic, the global T-cell lymphoma market is valued at US$ 1.44 billion in 2021, and it is expected to reach US$ 2.89 billion by 2030, with a CAGR of 8.4% during the forecast period of 2022-2030

Read more